eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Manuscripts accepted About the journal Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
1/2018
vol. 14
 
Share:
Share:
more
 
 
abstract:
Basic research

Differential action of polyunsaturated fatty acids and eicosanoids on bleomycin-induced cytotoxicity to neuroblastoma cells and lymphocytes

Sailaja Polavarapu, Bilikere S. Dwarakanath, Undurti N. Das

Arch Med Sci 2018; 14, 1: 207–229
Online publish date: 2017/12/19
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction: This study was conducted to examine whether bleomycin-induced growth inhibitory action on human neuroblastoma cells (IMR-32) is influenced by anti-inflammatory metabolites of polyunsaturated fatty acids (PUFAs): lipoxin A4 (LXA4), resolvin D1 and protectin D1 in vitro.

Material and methods: The in vitro study was conducted using monolayer cultures of exponentially growing IMR-32 cells. The effects of various PUFAs and eicosanoids and anti-inflammatory metabolites of PUFAs such as lipoxin A4 (LXA4), resolvin D1 and protectin D1 on the growth of IMR-32 cells and human lymphocytes in vitro were investigated. The potential of PUFAs, eicosanoids and LXA4, resolvin D1 and protectin D1 to modify the growth inhibitory effects of bleomycin was also studied in IMR-32 cells and human lymphocytes.

Results: PUFAs inhibited the growth of IMR-32 cells (EPA > DHA = AA > GLA = ALA > DGLA = LA) significantly (p < 0.001) while prostaglandins were found to be not effective. Bleomycin-induced growth inhibitory action on IMR-32 cells was augmented by PUFAs and its metabolites (p < 0.05). PUFAs and LXA4 did not inhibit the growth of human lymphocytes and bleomycin-induced growth inhibitory action was also not enhanced by these bioactive lipids.

Conclusions: Bioactive lipids have differential action on normal human lymphocytes and tumor cells in vitro. The apparent lack of effect of PUFAs in combination with bleomycin on the growth of human lymphocytes in comparison to their growth inhibitory action on IMR-32 cells suggests that PUFAs can be used in combination with bleomycin to target tumor cells with little concern over this combination’s effect on the growth of human lymphocytes. Further studies are warranted to evaluate these differential effects under in vivo conditions.
keywords:

polyunsaturated fatty acids, lipoxin A4, resolvin, protectin, prostaglandins, neuroblastoma, lymphocytes, bleomycin, cytotoxicity

references:
Begin ME, Ells G, Das UN, Horrobin DF. Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst 1986; 77: 1053-62.
Das UN. Tumoricidal action of cis-unsaturated fatty acids and its relationship to free radicals and lipid peroxidation. Cancer Lett 1991; 56: 235-43.
Ge H, Kong X, Shi L, Hou L, Liu Z, Li P. Gamma-linolenic acid induces apoptosis and lipid peroxidation in human chronic myelogenous leukemia K562cells. Cell Biol Int 2009; 33: 402-10.
Begin ME, Das UN, Ells G. Cytotoxic effects of essential fatty acids (EFA) in mixed cultures of normal and malignant human cells. Prog Lipid Res 1986; 25: 573-6.
Das UN. From bench to the clinic: c-linolenic acid therapy of human gliomas. Prostaglandins Leukot Essent Fatty Acids 2004; 70: 539-52.
Gillis RC, Daley BJ, Enderson BL, Karlstad MD. Eicosapentaenoic acid and gamma-linolenic acid induce apoptosis in HL-60 cells. J Surg Res 2002; 107: 145-53.
Madhavi N, Das UN. Effect of n-6 and n-3 fatty acids on the survival of vincristine sensitive and resistant human cervical carcinoma cells in vitro. Cancer Lett 1994; 84: 31-41.
Kumar GS, Das UN. Free radical dependent suppression of mouse myeloma cells by alpha-linolenic and eicosapentaenoic acids in vitro. Cancer Lett 1995; 92: 27-38.
Rizoo MT, Regazzi E, Garau D, et al. Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells. Cancer Res 1999; 59: 5047-53.
Ramesh G, Das UN. Effect of cis-unsaturated fatty acids on Meth-A ascitic tumor cells in vitro and in vivo. Cancer Letters 1998; 123: 207-14.
Vartak S, McCaw R, Davis CS, Robbins MEC, Spector AA. Gamma-linolenic acid (GLA) is cytotoxic to 36B10 malignant rat astrocytoma cells but not to ‘normal’ rat astrocytes. Br J Cancer 1998; 77: 1612-20.
Puskás LG, Fehér LZ, Vizler C, et al. Polyunsaturated fatty acids synergize with lipid droplet binding thalidomide analogs to induce oxidative stress in cancer cells. Lipids Health Dis 2010; 9: 56.
Faragó N, Fehér LZ, Kitajka K, Das UN, Puskás LG. MicroRNA profile of polyunsaturated fatty acid treated glioma cells reveal apoptosis-specific expression changes. Lipids Health Dis 2011; 10: 173.
Naidu MRC, Das UN, Kishan A. Intratumoral gamma-linolenic acid therapy of human gliomas. Prostaglandins Leukot Essent Fatty Acids 1992; 45: 181-4.
Das UN. Tumoricidal action of gamma-linolenic acid with particular reference to the therapy of human gliomas. Med Sci Res 1995; 23: 507-13.
Das UN, Prasad VSSV, Reddy DR. Local application of gamma-linolenic acid in the treatment of human gliomas. Cancer Lett 1995; 94: 147-55.
Bakshi A, Mukherjee D, Bakshi A, Banerji AK, Das UN. Gamma-linolenic acid therapy of human gliomas. Nutrition 2003; 19: 305-9.
Sangeetha PS, Das UN. Gamma-linolenic acid and eicosapentaenoic acid potentiate the cytotoxicity of anti-cancer drugs on human cervical carcinoma (HeLa) cells in vitro. Med Sci Res 1993; 21: 457-9.
Madhavi N, Das UN. Reversal of KB-3-1 and KB-Ch-8-5 tumor cell drug-resistance by cis-unsaturated fatty acids in vitro. Med Sci Res 1994; 22: 689-92.
Das UN, Madhavi N, Padma M, Sagar PS. Can tumor cell drug-resistance be reversed by essential fatty acids and their metabolites? Prostaglandins Leukot Essent Fatty Acids 1998; 58: 39-54.
Zijlstra JG, de Vries EG, Muskiet FA, Martini IA, Timmer-Bosscha H, Mulder NH. Influence of docosahexaenoic acid in vitro on intracellular adriamycin concentration in lymphocytes and human adriamycin-sensitive and -resistant small-cell lung cancer cell lines, and on cytotoxicity in the tumor cell lines. Int J Cancer 1987; 40: 850-6.
Buckingham LE, Balasubramanian M, Safa AR, et al. Reversal of multi-drug resistance in vitro by fatty acid-PEG-fatty acid diesters. Int J Cancer 1996; 65: 74-9.
Das UN, Madhavi N. Effect of polyunsaturated fatty acids on drug-sensitive and resistant tumor cells in vitro. Lipids Health Dis 2011; 10: 159.
Mengeaud V, Nano JL, Fournel S, Rampal P. Effects of eicosapentaenoic acid, gamma-linolenic acid and prostaglandin E1 on three human colon carcinoma cell lines. Prostaglandins Leukot Essent Fatty Acids 1882; 47: 313-9.
Botha JH, Robinson KM, Leary WP. The response of human carcinoma cell lines to gammalinolenic acid with special reference to the effects of agents which influence prostaglandin and thromboxane synthesis. Prostaglandins Leukot Med 1985; 19: 63-77.
Botha JH, Robinson KM, Ramchurren N, Norman RJ. The role of prostaglandins in the inhibition of cultured carcinoma cell growth produced by gamma-linolenic acid. Prostaglandins Leukot Essent Fatty Acids 1989; 35: 119-23.
Snyder DS, Castro R, Desforges JF. Antiproliferative effects of lipoxygenase inhibitors on malignant human hematopoietic cell lines. Exp Hematol 1989; 17: 6-9.
Avis I, Martınez A, Tauler J, et al. Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition. Cancer Res 2005; 65: 4181-90.
Scioscia KA, Snyderman CH, D’Amico F, et al. Effects of arachidonic acid metabolites in a murine model of squamous cell carcinoma. Head Neck 2000; 22: 149-55.
Santoro MG, Crisari A, Benedetto A, Amici C. Modulation of the growth of a human erythroleukemic cell line (K562) by prostaglandins: antiproliferative action of prostaglandin A. Cancer Res 1986; 46: 6073-7.
Ayyub Khan M, Tateson JE, Hoffbrand AV, Wickremasinghe RG. Evidence that endogenous generation of leukotrienes does not regulate viability of malignant haemopoietic cell lines. Leuk Res 1993; 17: 241-5.
Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998; 58: 362-6.
Sheng H, Shao J, Washington MK, DuBois RN. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 2001; 276: 18075-81.
Zweifel BS, Davis TW, Ornberg RL, Masferrer JL. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors. Cancer Res 2002; 62: 6706-11.
Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 2005; 310: 1504-10.
Yu L, Wu WK, Li ZJ, et al. Prostaglandin E(2) promotes cell viability via protein kinase C/extracellular signal regulated kinase pathway-dependent induction of c-Myc expression in human esophageal squamous cell carcinoma cells. Int J Cancer 2009; 125: 2540-6.
Claria J, Lee MH, Serhan CN. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell viability. Mol Med 1996; 2: 583-96.
Beckman BS, Despinasse BP, Spriggs L. Actions of lipoxins A4 and B4 on signal transduction events in friend erythroleukemia cells. Proc Soc Exp Biol Med 1992; 201: 169-73.
Das UN. Radiation resistance, invasiveness and metastasis are inflammatory events that could be suppressed by lipoxin A4. Prostaglandins Leukot Essent Fatty Acids 2012; 86: 3-11.
Hao H, Liu M, Wu P, et al. Lipoxin A4 and its analog suppress hepatocellular carcinoma via remodeling tumor microenvironment. Cancer Lett 2011; 309: 85-94.
Chen Y, Hao H, He S, et al. Lipoxin A4 and its analogue suppress the tumor growth of transplanted H22 in mice: the role of antiangiogenesis. Mol Cancer Ther 2010; 9: 2164-74.
Sailaja P, Mani AM, Naveen KVG, Devi AD, Siresha B, Das UN. Effect of polyunsaturated fatty acids and their metabolites on bleomycin-induced cytotoxic action on human neuroblastoma cells in vitro. PLoS One 2014; 9: e114766.
Das UN. Lipoxins, resolvins, protectins, maresins and nitrolipids and their clinical implications with specific reference to cancer: part I. Clin Lipidol 2013; 8: 437-63.
Das UN. Essential fatty acids enhance free radical generation and lipid peroxidation to induce apoptosis of tumor cells. Clin Lipidol 2011; 6: 463-89.
Kirkova M, Kassabova T, Russanov E. In vivo effects of indomethacin-I. Activity of antioxidant enzymes and lipid peroxidation. General Pharmacology 1992; 23: 503-7.
Lü JM, Nurko J, Weakley SM, et al. Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update. Med Sci Monit 2010; 16: RA93-100.
Hecht SM. Bleomycin: new perspectives on the mechanism of action. J Nat Prod 2000; 63: 158-68.
Orr FW, Adamson IY, Warner D, et al. The effects of oxygen radical: mediated pulmonary endothelial damage on cancer metastasis. Mol Cell Biochem 1988; 84: 189-98.
Ueta E, Osaki T, Yoneda K, Yamamoto T. Upregulation of respiratory burst of polymorphonuclear leukocytes by a bleomycin derivative, peplomycin. Free Radic Res 1995; 22: 533-44.
Das UN, Devi GR, Rao KP, Rao MS. Prostaglandins and their precursors can modify genetic damage induced by benzo(a)pyrene and gamma-radiation. Prostaglandins 1985; 29: 911-20.
Das UN, Rao KP. Effect of gamma-linolenic acid and prostaglandins E1 on gamma-radiation and chemical-
induced genetic damage to the bone marrow cells of mice. Prostaglandins Leukot Essent Fatty Acids 2006; 74: 165-73.
Shivani P, Rao KP, Chaudhury JR, et al. Effect of polyunsaturated fatty acids on diphenylhydantoin-induced genetic damage in-vitro and in vivo. Prostaglandins Leukot Essent Fatty Acids 2009; 80: 43-50.
Das UN, Devi R, Rao KP, Rao MS. Prostaglandins can modify gamma-radiation and chemical-induced cytotoxicity and genetic damage both in vitro and in vivo. Prostaglandins 1989; 38: 689-96.
Koratkar R, Das UN, Sangeetha PS, et al. Prostacyclin is a potent anti-mutagen. Prostaglandins Leukot Essent Fatty Acids 1993; 48: 175-84.
Das UN, Huang YS, Begin ME, Ells G, Horrobin DF. Uptake and distribution of cis-unsaturated fatty acids and their effect on free radical generation in normal and tumor cells in vitro. Free Rad Biol Med 1987; 3: 9-14.
Das UN, Begin ME, Ells G, Huang YS, Horrobin DF. Polyunsaturated fatty acids augment free radical generation in tumor-cells in vitro. Biochem Biophys Res Commun 1987; 145: 15-24.
Das UN. Tumoricidal action of cis-unsaturated fatty acids and their relationship to free radicals and lipid peroxidation. Cancer Lett 1991; 56: 235-43.
Das UN. A radical approach to cancer. Med Sci Monit 2002; 8: RA79-92.
Poorani R, Bhatt AN, Dwarakanath BS, Das UN. COX-2, aspirin and metabolism of arachidonic, eicosapentaenoic and docosahexaenoic acids and their physiological and clinical significance. Eur J Pharmacol 2016; 785: 116-32.
Köhnke T, Gomolka B, Bilal S, et al. Acetylsalicylic acid reduces the severity of dextran sodium sulfate-induced colitis and increases the formation of anti-inflammatory lipid mediators. Biomed Res Int 2013; 2013: 748160.
Brezinski DA, Nesto RW, Serhan CN. Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy. Circulation 1992; 86: 56-63.
Gilroy DW. New insights into the anti-inflammatory actions of aspirin-induction of nitric oxide through the generation of epilipoxins. Mem Inst Oswaldo Cruz 2005; 100 Suppl 1: 49-54.
Nishio E, Watanabe Y. Aspirin and salicylate enhances the induction of inducible nitric oxide synthase in cultured rat smooth muscle cells. Life Sci 1998; 63: 429-39.
Bolz SS, Pohl U. Indomethacin enhances endothelial NO release: evidence for a role of PGI2 in the autocrine control of calcium-dependent autacoid production. Cardiovasc Res 1997; 36: 437-44.
Beverelli F, Béa ML, Puybasset L, Giudicelli JF, Berdeaux A. Chronic inhibition of NO synthase enhances the production of prostacyclin in coronary arteries through upregulation of the cyclooxygenase type 1 isoform. Fundam Clin Pharmacol 1997; 11: 252-9.
Das UN, Mohan IK, Raju TR. Effect of corticosteroids and eicosapentaenoic acid/docosahexaenoic acid on pro-oxidant and anti-oxidant status and metabolism of essential fatty acids in patients with glomerular disorders. Prostaglandins Leukot Essent Fatty Acids 2001; 65: 197-203.
Das UN. Beneficial effect of eicosapentaenoic acid and docosahexaenoic acid in the management of systemic lupus erythematosus and its relationship to the cytokine network. Prostaglandins Leukot Essent Fatty Acids 1994; 51: 207-13.
Das UN. Beneficial action(s) of eicosapentaenoic acid/docosahexaenoic acid and nitric oxide in systemic lupus erythematosus. Med Sci Res 1995; 23: 723-6.
Das UN. Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation. J Inflamm Res 2010; 3: 143-70.
Das UN. Lipoxins as biomarkers of lupus and other inflammatory conditions. Lipids Health Dis 2011; 10: 76.
Serhan CN, Chiang N, Dalli J, Levy BD. Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol 2014; 7: a016311.
Tang H, Liu Y, Yan C, Petasis NA, Serhan CN, Gao H. Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury. J Immunol 2014; 193: 3769-78.
Gundala NKV, Naidu VGM, Das UN. Arachidonic acid and lipoxin A4 attenuate alloxan-induced cytotoxicity to RIN5F cells in vitro and type 1 diabetes mellitus in vivo. BioFactors 2017; 43: 251-71.
Gundala NKV, Naidu VGM, Das UN. Arachidonic acid and lipoxin A4 attenuate streptozotocin-induced cytotoxicity to RIN5F cells in vitro and type 1 and type 2 diabetes mellitus in vivo. Nutrition 2017; 35: 61-80.
Zhang C, Yu H, Shen Y, Ni X, Shen S, Das UN. Polyunsaturated fatty acids trigger apoptosis of colon cancer cells through a mitochondrial pathway. Arch Med Sci 2015; 11: 1081-94.
Yu H, Liu Y, Pan W, Shen S, Das UN. Polyunsaturated fatty acids augment tumoricidal action of 5-fluorouracil on gastric cancer cells by their action on vascular endothelial growth factor, tumor necrosis factor-alpha and lipid metabolism related factors. Arch Med Sci 2015; 11: 282-91.
Antal O, Hackler L Jr, Shen J, et al. Combination of unsaturated fatty acids and ionizing radiation on human glioma cells: cellular, biochemical and gene expression analysis. Lipids Health Dis 2014; 13: 142.
Antal O, Péter M, Hackler L Jr, et al. Lipidomic analysis reveals a radiosensitizing role of gamma-linolenic acid in glioma cells. Biochim Biophys Acta 2015; 1851: 1271-82.
FEATURED PRODUCTS
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe